These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 11304766)
1. Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells. Gandhi V; Plunkett W; Weller S; Du M; Ayres M; Rodriguez CO; Ramakrishna P; Rosner GL; Hodge JP; O'Brien S; Keating MJ J Clin Oncol; 2001 Apr; 19(8):2142-52. PubMed ID: 11304766 [TBL] [Abstract][Full Text] [Related]
2. Phase I trial of nelarabine in indolent leukemias. Gandhi V; Tam C; O'Brien S; Jewell RC; Rodriguez CO; Lerner S; Plunkett W; Keating MJ J Clin Oncol; 2008 Mar; 26(7):1098-105. PubMed ID: 18309944 [TBL] [Abstract][Full Text] [Related]
3. Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. Gandhi V; Plunkett W; Rodriguez CO; Nowak BJ; Du M; Ayres M; Kisor DF; Mitchell BS; Kurtzberg J; Keating MJ J Clin Oncol; 1998 Nov; 16(11):3607-15. PubMed ID: 9817282 [TBL] [Abstract][Full Text] [Related]
4. A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells. Yamauchi T; Nishi R; Kitazumi K; Nakano T; Ueda T Oncol Rep; 2010 Feb; 23(2):499-504. PubMed ID: 20043113 [TBL] [Abstract][Full Text] [Related]
5. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy. Gandhi V; Estey E; Du M; Keating MJ; Plunkett W Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841 [TBL] [Abstract][Full Text] [Related]
6. Nelarabine: a nucleoside analog with efficacy in T-cell and other leukemias. Kisor DF Ann Pharmacother; 2005 Jun; 39(6):1056-63. PubMed ID: 15870141 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group. Avramis VI; Wiersma S; Krailo MD; Ramilo-Torno LV; Sharpe A; Liu-Mares W; Kowck R; Reaman GH; Sato JK Clin Cancer Res; 1998 Jan; 4(1):45-52. PubMed ID: 9516951 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia. Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970 [TBL] [Abstract][Full Text] [Related]
9. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. Gandhi V; Estey E; Keating MJ; Plunkett W J Clin Oncol; 1993 Jan; 11(1):116-24. PubMed ID: 8418222 [TBL] [Abstract][Full Text] [Related]
10. Phase I study of nelarabine in patients with relapsed or refractory T-ALL/T-LBL. Horibe K; Takimoto T; Yokozawa T; Makimoto A; Kobayashi Y; Ogawa C; Ohno R; Koh N; Katsura K; Tobinai K Rinsho Ketsueki; 2011 Jun; 52(6):406-15. PubMed ID: 21737993 [TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells. Rodriguez CO; Plunkett W; Paff MT; Du M; Nowak B; Ramakrishna P; Keating MJ; Gandhi V J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(2):421-30. PubMed ID: 11043760 [TBL] [Abstract][Full Text] [Related]
12. Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia. Gandhi V; Kemena A; Keating MJ; Plunkett W Cancer Res; 1992 Feb; 52(4):897-903. PubMed ID: 1737352 [TBL] [Abstract][Full Text] [Related]
13. Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology. Gandhi V; Robertson LE; Keating MJ; Plunkett W Cancer Chemother Pharmacol; 1994; 34(1):30-6. PubMed ID: 8174200 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies. Kisor DF; Plunkett W; Kurtzberg J; Mitchell B; Hodge JP; Ernst T; Keating MJ; Gandhi V J Clin Oncol; 2000 Mar; 18(5):995-1003. PubMed ID: 10694549 [TBL] [Abstract][Full Text] [Related]
16. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia. Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959 [TBL] [Abstract][Full Text] [Related]
17. Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature. Aguayo A; Cortes JE; Kantarjian HM; Beran M; Gandhi V; Plunkett W; Kurtzberg J; Keating MJ Cancer; 1999 Jan; 85(1):58-64. PubMed ID: 9921974 [TBL] [Abstract][Full Text] [Related]
18. Cellular and clinical pharmacology of fludarabine. Gandhi V; Plunkett W Clin Pharmacokinet; 2002; 41(2):93-103. PubMed ID: 11888330 [TBL] [Abstract][Full Text] [Related]
19. A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies. Boddu PC; Senapati J; Ravandi-Kashani F; Jabbour EJ; Jain N; Ayres M; Chen Y; Keating MJ; Kantarjian HM; Gandhi V; Kadia TM Cancer; 2023 Feb; 129(4):580-589. PubMed ID: 36448227 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological and biochemical strategies to increase the accumulation of arabinofuranosylguanine triphosphatein primary human leukemia cells. Rodriguez CO; Legha JK; Estey E; Keating MJ; Gandhi V Clin Cancer Res; 1997 Nov; 3(11):2107-13. PubMed ID: 9815603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]